Draper has signed a three-year deal with Big Pharma giant Pfizer to help predict clinical outcomes from an early stage through the use of its…

Aptuit, a CRO focused on early to mid-phase drug development, has inked a deal with Chiesi Farmaceutici to develop new drugs for idiopathic pulmonary fibrosis.

Crown Bioscience will invest $1 million into establishment of a pharmaceutical R&D facility in Louisiana at New Iberia Research Center, one of the country’…

The European Medicines Agency recently held a workshop with stakeholders about adaptive pathways, which also allows more real-world data into drug approvals.

Insufficient enrollment is one of the biggest challenges for clinical trials. A new patients finder tool has been launched by UCSF to help connect clinical…

Center Point Clinical Services is trying to translate digital tools' advantages of better communication and fewer costs into clinical research, as it…

A predictive model could help clinicians decide whether prostate cancer patients should be offered standard treatment or the chance to enter a clinical trial.

London-based trial services co Ergomed has penned a deal with Swedish biotech Asarina Pharma for its Phase IIb trial of sepranolone in patients with…

Cancer-related trials continued to account for the largest number of research studies done by CROs in any region of the world, says a new report.

R&D